Interleukin-21
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 23–155 | Not recorded | No other associated polymer | SOLUTION NMR NMR measurement conditions:pH 5.5;300 K;Ionic strength (raw mmCIF value) 50mM NaCl;Pressure ambient NMR sample composition:0.8mM IL21 U-15N, 20mM phosphate, 50mM NaCl, 1mM NaN3 | 90% H2O/10% D2O NMR sample composition:0.8mM IL21 U-15N,13C, 20mM phosphate, 50mM NaCl, 1mM NaN3 | 100% D2O | Resolution not provided |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 2OQP | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 3TGX IL-21:IL21R complex Deposited 2011-08-18 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
23–155(133 aa)
Fragment:unp RESIDUES 23-155
|
Not recorded | MAN alpha-D-mannopyranose × 1 NI NICKEL (II) ION × 1 SO4 SULFATE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.3 K;1,8-1,9 M di-Ammonium sulphate and 0.1 M Sodium acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 291.3K
|
Resolution 2.80 Å R-free 0.273 |
| 3TGX IL-21:IL21R complex Deposited 2011-08-18 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
23–155(133 aa)
Fragment:unp RESIDUES 23-155
|
Not recorded | MAN alpha-D-mannopyranose × 1 SO4 SULFATE ION × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.3 K;1,8-1,9 M di-Ammonium sulphate and 0.1 M Sodium acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 291.3K
|
Resolution 2.80 Å R-free 0.273 |
| 3TGX IL-21:IL21R complex Deposited 2011-08-18 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain F
23–155(133 aa)
Fragment:unp RESIDUES 23-155
|
Not recorded | MAN alpha-D-mannopyranose × 1 NI NICKEL (II) ION × 1 SO4 SULFATE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.3 K;1,8-1,9 M di-Ammonium sulphate and 0.1 M Sodium acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 291.3K
|
Resolution 2.80 Å R-free 0.273 |
| 3TGX IL-21:IL21R complex Deposited 2011-08-18 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain H
23–155(133 aa)
Fragment:unp RESIDUES 23-155
|
Not recorded | MAN alpha-D-mannopyranose × 1 NI NICKEL (II) ION × 1 SO4 SULFATE ION × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.3 K;1,8-1,9 M di-Ammonium sulphate and 0.1 M Sodium acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 291.3K
|
Resolution 2.80 Å R-free 0.273 |
| 3TGX IL-21:IL21R complex Deposited 2011-08-18 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain J
23–155(133 aa)
Fragment:unp RESIDUES 23-155
|
Not recorded | MAN alpha-D-mannopyranose × 1 SO4 SULFATE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.3 K;1,8-1,9 M di-Ammonium sulphate and 0.1 M Sodium acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 291.3K
|
Resolution 2.80 Å R-free 0.273 |
| 3TGX IL-21:IL21R complex Deposited 2011-08-18 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain L
23–155(133 aa)
Fragment:unp RESIDUES 23-155
|
Not recorded | MAN alpha-D-mannopyranose × 1 SO4 SULFATE ION × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.3 K;1,8-1,9 M di-Ammonium sulphate and 0.1 M Sodium acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 291.3K
|
Resolution 2.80 Å R-free 0.273 |
| 3TGX IL-21:IL21R complex Deposited 2011-08-18 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 7 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain N
23–155(133 aa)
Fragment:unp RESIDUES 23-155
|
Not recorded | MAN alpha-D-mannopyranose × 1 SO4 SULFATE ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.3 K;1,8-1,9 M di-Ammonium sulphate and 0.1 M Sodium acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 291.3K
|
Resolution 2.80 Å R-free 0.273 |
| 3TGX IL-21:IL21R complex Deposited 2011-08-18 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 8 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain P
23–155(133 aa)
Fragment:unp RESIDUES 23-155
|
Not recorded | MAN alpha-D-mannopyranose × 1 NI NICKEL (II) ION × 1 SO4 SULFATE ION × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.3 K;1,8-1,9 M di-Ammonium sulphate and 0.1 M Sodium acetate, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 291.3K
|
Resolution 2.80 Å R-free 0.273 |
| 8ENT Interleukin-21 signaling complex with IL-21R and IL-2Rg Deposited 2022-09-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain A
30–162(133 aa)
|
Mutation:N68Q | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;295 K;0.1M Tris pH 8, 20% PEG 6000
|
Resolution 2.83 Å R-free 0.300 |
| 8ENT Interleukin-21 signaling complex with IL-21R and IL-2Rg Deposited 2022-09-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric |
Chain D
30–162(133 aa)
|
Mutation:N68Q | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 EDO 1,2-ETHANEDIOL × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;295 K;0.1M Tris pH 8, 20% PEG 6000
|
Resolution 2.83 Å R-free 0.300 |
| 8ENT Interleukin-21 signaling complex with IL-21R and IL-2Rg Deposited 2022-09-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Other combination Heteromer;Protein × 3 PDB declaration: trimeric |
Chain G
30–162(133 aa)
|
Mutation:N68Q | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;295 K;0.1M Tris pH 8, 20% PEG 6000
|
Resolution 2.83 Å R-free 0.300 |
| 8ENT Interleukin-21 signaling complex with IL-21R and IL-2Rg Deposited 2022-09-30 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Other combination Heteromer;Protein × 2 PDB declaration: dimeric |
Chain J
30–162(133 aa)
|
Mutation:N68Q | EDO 1,2-ETHANEDIOL × 6 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;295 K;0.1M Tris pH 8, 20% PEG 6000
|
Resolution 2.83 Å R-free 0.300 |
2 other PDB entries and 12 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | IL21_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 2–134; UniProt 23–155 |